CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Astrocytes are highly complex cells that tightly envelope synaptic structures in the brain. This picture shows 3D-printed forms of astrocytes

November 12, 2020 | Duke Today

Astrocytes Identified as Master ‘Conductors’ of the Brain

Star-shaped ‘glue’ cells make it their business to govern connections between neurons

mini lung

October 23, 2020 | Duke Today

Lab-grown Mini-lungs Mimic the Real Thing – Right Down to COVID Infection

Living human lung air sacs in tiny dishes promise to accelerate COVID research

crystal structure of DNA

October 22, 2020 | Duke School of Medicine

Transcription factors may inadvertently lock in DNA mistakes

Transcription factor proteins are the light switches of the human genome.